By G HossainPosted on September 22, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The acquisition of breakout obesity star Metsera should pump new life into Pfizer’s portfolio, which over the last two years has suffered from three discontinued assets. Pfizer Stages Obesity Comeback With $4.9B Metsera Acquisition Post navigation Novartis Looking for Constructive Ways To Bring Down Drug Costs in USBoomer’s Blueprint: Experimentation for growth and relevance